ArticleFrontiers in oncology2023

HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer.

Ulrika Pellas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.